Navigation Links
Novartis Highlights Advances for Patients With Breast Cancer and Hematological Diseases With Over 160 SABCS and ASH Abstracts
Date:12/1/2011

atients with rare hereditary problems of galactose intolerance, severe lactase deficiency with a severe degree of intolerance to lactose-containing products, or of glucose-galactose malabsorption.
  • Women of childbearing potential should avoid becoming pregnant while taking TASIGNA and should be advised of the potential hazard to the fetus if they do. The safety and effectiveness of TASIGNA in pediatric patients have not been established.
  • In newly diagnosed Ph+ CML-chronic phase, the most commonly reported nonhematologic adverse drug reactions (>10%) were rash, pruritus, headache, nausea, fatigue, and myalgia.
  • In resistant or intolerant Ph+ CML-chronic phase, the most commonly reported nonhematologic adverse drug reactions (greater than or equal to 10%) were rash, pruritus, nausea, fatigue, headache, constipation, diarrhea, vomiting, and myalgia.
  • In resistant or intolerant Ph+ CML-accelerated phase, the most commonly reported nonhematologic adverse drug reactions (greater than or equal to 10%) were rash, pruritus, and fatigue.
  • TASIGNA may need to be temporarily withheld and/or dose reduced for QT prolongation, hematologic toxicities that are not related to underlying leukemia, clinically significant moderate or severe nonhematologic toxicities, laboratory abnormalities, or concomitant use of strong CYP3A4 inhibitors.

    • Please see full Prescribing Information including Boxed Warning.

    About Gleevec
    Gleevec® (imatinib mesylate) tablets are indicated for newly diagnosed adult patients with Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML) in the chronic phase (CP). Gleevec is also indicated for the treatment of patients with Ph+ CML in blast crisis (BC), accelerated phase (AP), or in CP after failure of interferon-alpha therapy.

    GLEEVEC Important Safety Information
    GLEEVEC is often associated wit
    '/>"/>

    SOURCE Novartis Pharmaceuticals Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

    Related biology technology :

    1. Novartis Phase III Study Shows ACZ885 Helped Substantially Reduce Steroid Use in 45% of Patients With Serious Form of Childhood Arthritis
    2. Genentech and Novartis Remain Image Leaders in Oncology and Hematology
    3. FDA Advisory Committee Recommends US Approval of Novartis Once-daily Bronchodilator QAB149 for COPD
    4. Novartis Drug Afinitor® Extends Progression-Free Survival in Patients With Advanced Pancreatic NET, Study Published in NEJM Shows
    5. With the Recent Launch of Novartiss Gilenya, Extavia is Pushed Into the Background of Multiple Sclerosis Treatment One Year After its Launch
    6. VIDEO from Novartis Available on thenewsmarket.com: Novartis Presents Data about Tasigna in Treatment of Patients with Newly Diagnosed Ph+ Chronic Myeloid Leukemia
    7. Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon
    8. Silence Therapeutics Partner Quark Signs Exclusive Option Agreement With Novartis for Development and Commercialisation of QPI-1002
    9. Novartis Class Awarded $250 Million in Punitive Damages
    10. Heptares Therapeutics Announces Agreement With Novartis Option Fund to Apply its StaR(TM) Technology and Generate Novel Drug Leads Against a GPCR Target
    11. Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/14/2013)... 2013  Stem cells have long been touted as the ... to Dr. Dennis Lox , some patients with a ... to stem cell therapy for aid. Avascular necrosis (AVN) also ... in which the blood supply to the bone becomes disrupted, ... to as necrosis. The region may be very painful, and ...
    (Date:6/14/2013)... DIEGO , June 14, 2013  Mast Therapeutics, ... an underwritten public offering of 50,000,000 units, each unit ... common stock and one warrant to purchase 0.5 of ... price of $0.50 per unit.  The units will not ... stock and the warrants are immediately separable and will ...
    (Date:6/14/2013)... Toronto, ON / Boston, MA (PRWEB) June 14, ... the world’s largest independent resource for life scientists ... new e-commerce features within the growing 1DegreeBio marketplace. ... quickly browse through hundreds of vendor catalogues, access ... create purchase orders, email products to lab managers ...
    (Date:6/13/2013)... Eagle Biosciences is proud to announce ... Calprotectin ELISA assay kit that offers the ... µg/g stool). The Calprotectin ELISA assay kit is ... Calprotectin (neutrophil cytoplasmic protein s100A8/A9, MRP 8/14) in ... assay line which already includes Alpha 1 Antitrypsin ...
    Breaking Biology Technology:Stem Cells May Help Some With Avascular Necrosis (AVN) 2Mast Therapeutics Prices Public Offering Of Units 2Mast Therapeutics Prices Public Offering Of Units 3Mast Therapeutics Prices Public Offering Of Units 41DegreeBio Inc. Boosts Review-Driven Reagent Marketplace with New e-Commerce Platform 2Eagle Biosciences Introduces Highly Sensitive Calprotectin ELISA Assay Kit 2
    ... Mass., May 9 Millstone Medical Outsourcing,announced ... ISO 13485,certified quality system to the Memphis, ... the world,s largest developer and,publisher of international ... a highly-experienced quality engineer, to serve as ...
    ... 9 The International Center for Adult,Stem ... that,it has officially launched a global communications ... Spinal Cord Injury Symposium,Olfactory Mucosa Autografts (OMA) ... through May 10th in Argostolli, Kefalonia, Greece. ...
    ... announced financial results for the first quarter 2008. Novavax,reported a ... the first,quarter of 2008 compared to a net loss of ... 2007. Total cash and short-term investments,as of March 31, 2008 ... 2007. The cash burn for the quarter was $5.6 million., ...
    Cached Biology Technology:Millstone Medical Outsourcing Achieves Quality Advantages in Memphis: Certified ISO 13485, Hires Experienced Quality Manager 2International Center for Adult Stem Cell Education Debuts at Spinal Cord Injury Symposium in Greece 2Novavax Reports First Quarter 2008 Financial Results 2Novavax Reports First Quarter 2008 Financial Results 3Novavax Reports First Quarter 2008 Financial Results 4Novavax Reports First Quarter 2008 Financial Results 5Novavax Reports First Quarter 2008 Financial Results 6Novavax Reports First Quarter 2008 Financial Results 7Novavax Reports First Quarter 2008 Financial Results 8
    (Date:6/14/2013)... will collaborate with researchers from Oklahoma State University, ... of Tulsa to advance understanding of how socio-ecological ... and variability in the state. , Oklahoma ... $20 million National Science Foundation Experimental Program to ... innovative research over the next five years. ...
    (Date:6/14/2013)... work carried out by the Carbohydrate Metabolism Research ... jointly owned by the NUP/UPNA-Public University of Navarre, ... Government of Navarre), the discovery has been made ... (now renamed as the "surface composition regulator", scoR) ... in bacterial infection can be altered by manipulating ...
    (Date:6/14/2013)... week in the journal Science , Swedish and ... million year old fossil fishes, revealed by unique fossils ... help scientists to understand how neck muscles and abdominal ... naturally conjures up a vision of rattling skeletons. Bones ... and are usually the only traces of the animal ...
    Breaking Biology News(10 mins):OU researchers collaborate on $20 million NSF EPSCoR grant 2OU researchers collaborate on $20 million NSF EPSCoR grant 3Discovery of how a gene that regulates factors involved in bacteria pathogenicity acts 2Discovery of how a gene that regulates factors involved in bacteria pathogenicity acts 3
    ... This release is available in Spanish . ... oldest persons in the world, who recently died at the ... which could have contributed to this longevity. The research team, ... pointed out a healthy lifestyle, a Mediterranean diet, a temperate ...
    ... may have an important role to play in the fate ... recent war campaigns, according to a new report in the ... Press. The researchers found evidence that fungi can ... less likely to find its way into plants, animals, or ...
    ... plague may be more virulent than their close relatives because ... the May issue of the journal Microbiology. The plague ... body temperature. When there is no calcium available, it produces ... said Professor Brubaker from the University of Chicago, USA. We ...
    Cached Biology News:The secret to long life may not be in the genes 2Fungi have a hand in depleted uranium's environmental fate 2
    ... Serum • Cyno serum is collected off the clot ... years of age. Available Anticoagulants: ... N-06: K2EDTA N-08: Potassium Oxalate ... N-05: ACD N-07: CPD N-09: ...
    All serum is collected from adult animals aged 6 months or older. Certified U.S. orgin. Pricing: $35/unit for 1 - 10 units...
    adult...
    DNA Purification...
    Biology Products: